Structure and Function of GOLGA6C: Potential Drug Target Or Biomarker

Target Name: GOLGA6C

NCBI ID: G653641

GOLGA6C

Structure and Function of GOLGA6C: Potential Drug Target Or Biomarker

GOLGA6C (Golgin subfamily A member 6C) is a protein that is expressed in various tissues throughout the body. It is a key player in the Golgi system, which is a network of vesicular organelles that plays a crucial role in cell signaling and metabolism . GOLGA6C is a 21-kDa protein that consists of 195 amino acid residues. It has a unique structure that is composed of a catalytic active center, a 尾-sheet, and a 纬-sheet.

GOLGA6C is a member of the Golgi subfamily A, which is characterized by the presence of a catalytic active center and a 尾-sheet. The 尾-sheet is a transmembrane region that is composed of alternating 尾-strands that are responsible for the protein's stability and localization to the membrane. The 纬-sheet is an extracellular region that is composed of a series of 纬-helices that is responsible for the protein's interactions with other proteins and other cell structures.

GOLGA6C is expressed in a variety of tissues throughout the body, including the brain, pancreas, and heart. It is involved in the regulation of various cellular processes, including cell signaling, metabolism, and inflammation. GOLGA6C is also associated with a number of diseases , including cancer, neurodegenerative diseases, and autoimmune diseases.

Due to its unique structure and involvement in various cellular processes, GOLGA6C has potential as a drug target or biomarker. Studies have shown that GOLGA6C is involved in a number of signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. GOLGA6C has also been shown to play a role in the regulation of cellular adhesion, adhesion, and migration.

In addition to its potential as a drug target or biomarker, GOLGA6C is also of interest as a potential therapeutic agent for a variety of diseases. For example, GOLGA6C has been shown to be involved in the regulation of cancer cell proliferation and survival. Studies have shown that inhibiting GOLGA6C activity can lead to a reduction in cancer cell growth and the formation of new blood vessels.

GOLGA6C is also of interest as a potential biomarker for several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Studies have shown that reducing GOLGA6C activity in neurodegenerate brain cells can lead to a reduction in the severity of neurodegeneration.

In conclusion, GOLGA6C is a protein that is expressed in various tissues throughout the body and is involved in the regulation of various cellular processes. Its unique structure, as well as its involvement in multiple signaling pathways, makes it a potential drug target or biomarker. Further research is needed to fully understand the role of GOLGA6C in cellular processes and its potential as a therapeutic agent.

Protein Name: Golgin A6 Family Member C

The "GOLGA6C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLGA6C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets